Sphingomyelinase D, a novel probe for cellular sphingomyelin

Sphingomyelinase D, a novel probe for cellular sphingomyelin

Sphingomyelin (SM) and free cholesterol (FC) are concentrated in the plasma membranes of eukaryotes; however, the physiological significance of their association is unclear. A common tool for studying the role of membrane SM is digestion with bacterial sphingomyelinase (SMase) C, which hydrolyzes SM...

Full description

Bibliographic Details
Main Authors:	Papasani V. Subbaiah, Stephen J. Billington, B. Helen Jost, J. Glenn Songer, Yvonne Lange
Format:	Article
Language:	English
Published:	Elsevier 2003-08-01
Series:	Journal of Lipid Research
Subjects:	ceramide ceramide phosphate acyl-CoA:cholesterol acyltransferase cholesterol efflux sphingomyelin sphingomyelinase
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520337688

Similar Items

Macrophage cholesterol efflux and the active domains of serum amyloid A 2.1
by: Robert Kisilevsky, et al.
Published: (2003-12-01)

Sphingomyelinases and Liver Diseases
by: Naroa Insausti-Urkia, et al.
Published: (2020-10-01)

Thematic Review Series: Sphingolipids. Nuclear sphingolipids: metabolism and signaling*
by: Robert W. Ledeen, et al.
Published: (2008-06-01)

Identification of ACAT1- and ACAT2-specific inhibitors using a novel, cell-based fluorescence assay
by: Aaron T. Lada, et al.
Published: (2004-02-01)

Expression of Ceramide-Metabolizing Enzymes in the Heart Adipose Tissue of Cardiovascular Disease Patients
by: Olga Gruzdeva, et al.
Published: (2023-05-01)

Thematic Review Series: Sphingolipids. ISC1 (inositol phosphosphingolipid-phospholipase C), the yeast homologue of neutral sphingomyelinases*
by: Nabil Matmati, et al.
Published: (2008-05-01)

Sphingolipids: Important Players in Multiple Sclerosis
by: Ramona Halmer, et al.
Published: (2014-06-01)

PMA activation of macrophages alters macrophage metabolism of aggregated LDL
by: Wei Huang, et al.
Published: (2002-08-01)

ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions
by: Ashley M. Vaughan, et al.
Published: (2003-07-01)

ACAT1/SOAT1 Blockade Suppresses LPS-Mediated Neuroinflammation by Modulating the Fate of Toll-like Receptor 4 in Microglia
by: Haibo Li, et al.
Published: (2023-03-01)

Trafficking defects in endogenously synthesized cholesterol in fibroblasts, macrophages, hepatocytes, and glial cells from Niemann-Pick type C1 mice
by: Patrick C. Reid, et al.
Published: (2003-05-01)

Sphingomyelinase D/Ceramide 1-Phosphate in Cell Survival and Inflammation
by: Io-Guané Rivera, et al.
Published: (2015-04-01)

Modulation of the activity and arachidonic acid selectivity of group X secretory phospholipase A2 by sphingolipids
by: Dev K. Singh, et al.
Published: (2007-03-01)

Early postoperative changes of sphingomyelins and ceramides after laparoscopic sleeve gastrectomy
by: Hakan Özer, et al.
Published: (2018-11-01)

ABCA1-dependent sterol release: sterol molecule specificity and potential membrane domain for HDL biogenesis
by: Yoshio Yamauchi, et al.
Published: (2016-01-01)

Regulation of Arthritis Severity by the Acid Sphingomyelinase
by: Nadine Beckmann, et al.
Published: (2017-10-01)

Inhibition of acid sphingomyelinase by tricyclic antidepressants and analogons
by: Nadine eBeckmann, et al.
Published: (2014-09-01)

New Molecular Targets for Antidepressant Drugs
by: Johannes Kornhuber, et al.
Published: (2021-09-01)

Endothelial NLRP3 inflammasome activation and arterial neointima formation associated with acid sphingomyelinase during hypercholesterolemia
by: Saisudha Koka, et al.
Published: (2017-10-01)

Effect of Sphingomyelinase-Treated LDLs on HUVECs
by: Angelica Giuliani, et al.
Published: (2023-02-01)

Identification of an acid sphingomyelinase ceramide kinase pathway in the regulation of the chemokine CCL5 [S]
by: Benjamin Newcomb, et al.
Published: (2018-01-01)

Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study
by: Paul N. Jensen, et al.
Published: (2022-08-01)

Sphingomyelinase acts by an area-activated mechanism on the liquid-expanded phase of sphingomyelin monolayers
by: Luisina De Tullio, et al.
Published: (2008-11-01)

Staphylococcus aureus α-Toxin Induces Inflammatory Cytokines via Lysosomal Acid Sphingomyelinase and Ceramides
by: Jie Ma, et al.
Published: (2017-10-01)

Sphingomyelinase Disables Inactivation in Endogenous PIEZO1 Channels
by: Jian Shi, et al.
Published: (2020-10-01)

Molecular docking as a tool for the discovery of novel insight about the role of acid sphingomyelinase inhibitors in SARS- CoV-2 infectivity
by: Samar Sami Alkafaas, et al.
Published: (2024-02-01)

Crosstalk Between Acid Sphingomyelinase and Inflammasome Signaling and Their Emerging Roles in Tissue Injury and Fibrosis
by: Cao Li, et al.
Published: (2020-01-01)

Paradoxical effect on atherosclerosis of hormone-sensitive lipase overexpression in macrophages
by: Jean-Louis Escary, et al.
Published: (1999-03-01)

Re-Configuration of Sphingolipid Metabolism by Oncogenic Transformation
by: Anthony S. Don, et al.
Published: (2014-03-01)

Characterization of the small molecule ARC39, a direct and specific inhibitor of acid sphingomyelinase in vitro[S]
by: Eyad Naser, et al.
Published: (2020-06-01)

The Role of Sphingomyelin and Ceramide in Motor Neuron Diseases
by: Gavin McCluskey, et al.
Published: (2022-08-01)

Mechanisms of sphingosine and sphingosine 1-phosphate generation in human platelets
by: Motohiro Tani, et al.
Published: (2005-11-01)

Sphingolipids and cholesterol modulate membrane susceptibility to cytosolic phospholipase A2
by: Elsa Klapisz, et al.
Published: (2000-10-01)

Acid sphingomyelinase promotes diabetic cardiomyopathy via NADPH oxidase 4 mediated apoptosis
by: Ruijiao Liu, et al.
Published: (2023-02-01)

Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: integrated activities of hepatic lipid regulatory enzymes1
by: Frank Lammert, et al.
Published: (1999-11-01)

Administration of an Acidic Sphingomyelinase (ASMase) Inhibitor, Imipramine, Reduces Hypoglycemia-Induced Hippocampal Neuronal Death
by: A Ra Kho, et al.
Published: (2022-02-01)

Changes in membrane biophysical properties induced by sphingomyelinase depend on the sphingolipid N-acyl chain
by: Sandra N. Pinto, et al.
Published: (2014-01-01)

Neutral sphingomyelinase activation in endothelial and glial cell death induced by amyloid beta-peptide
by: Ding-I Yang, et al.
Published: (2004-10-01)

The Activity of the Neutral Sphingomyelinase Is Important in T Cell Recruitment and Directional Migration
by: Lena Collenburg, et al.
Published: (2017-08-01)

Mechanisms of Arachidonic Acid In Vitro Tumoricidal Impact
by: Hatem Tallima, et al.
Published: (2023-02-01)